Ms. Cheng has a strong background in finance with more than 25 years of experience as a finance executive including more than 15 years at Visy Industries/Pratt Holdings and 10 years in investment banking. She has significant commercial and international corporate expertise including experience in financial services, manufacturing, export finance, infrastructure, education as well as market entry, growth, and technology.
Ms. Cheng is currently Director of Corporate Development and Mergers & Acquisitions at Visy Industries / Pratt Holdings and has held various other roles in the group including CFO. Ms Cheng’s earlier roles include as a lawyer at Blake Dawson, before moving into investment banking with J.P. Morgan in their Melbourne, Sydney, San Francisco, and New York offices.
Ms. Cheng is currently a non-executive director of Export Finance Australia. In March 2022, Lynda also became an independent, non-executive member of the board of directors JRJJ Capital, the parent co of Merricks Capital, in an observer/advisory capacity. Ms Cheng previously served as a member of the Australian Government's International Development Policy Expert Panel, Deputy Chair and Chair of the Finance, Audit and Risk Committee of South East Water and as a member of the Wesley College Council.
Ms. Cheng holds a Bachelor of Law (Honours) and Commerce degree, majoring in actuarial studies and economics, from the University of Melbourne and is a graduate member of the Australian Institute of Company Directors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Starpharma
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products.